A Dual Targeting Drug Delivery System for Penetrating Blood-Brain Barrier and Selectively Delivering siRNA to Neurons for Alzheimer’s Disease Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|18|14|1124-1131

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.18, Iss.14, 2018-04, pp. : 1124-1131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 19, Iss. 37, 2013-11 ,pp. : 6635-6646

Bentham Science Publishers

Access to resources Recommend Favorite

Drug delivery to brain via the blood-brain barrier

By Scherrmann J.-M.  

General Pharmacology, Vol. 38, Iss. 6, 2002-06 ,pp. : 349-354

Elsevier

Access to resources Recommend Favorite

Drug Delivery Across the Blood-Brain Barrier

By  

Current Drug Delivery, Vol. 1, Iss. 4, 2004-10 ,pp. : 361-376

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)

By Ulbrich Karsten   Knobloch Thomas   Kreuter Jörg  

Journal of Drug Targeting, Vol. 19, Iss. 2, 2011-02 ,pp. : 125-132

Informa Healthcare

Access to resources Recommend Favorite

Nanoparticle- and Liposome-carried Drugs: New Strategies for Active Targeting and Drug Delivery Across Blood-brain Barrier

By  

Current Drug Metabolism, Vol. 14, Iss. 6, 2013-07 ,pp. : 625-640

Bentham Science Publishers

Access to resources Recommend Favorite